1. Home
  2. SNTI vs DAIO Comparison

SNTI vs DAIO Comparison

Compare SNTI & DAIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Senti Biosciences Inc.

SNTI

Senti Biosciences Inc.

HOLD

Current Price

$1.10

Market Cap

24.5M

Sector

Health Care

ML Signal

HOLD

Logo Data I/O Corporation

DAIO

Data I/O Corporation

N/A

Current Price

$2.58

Market Cap

22.3M

Sector

Industrials

ML Signal

N/A

Company Overview

Basic Information
Metric
SNTI
DAIO
Founded
2016
1969
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Electrical Products
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
24.5M
22.3M
IPO Year
2021
1995

Fundamental Metrics

Financial Performance
Metric
SNTI
DAIO
Price
$1.10
$2.58
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
4
1
Target Price
$8.50
$5.22
AVG Volume (30 Days)
141.9K
51.5K
Earning Date
05-06-2026
05-14-2026
Dividend Yield
N/A
N/A
EPS Growth
77.31
N/A
EPS
N/A
N/A
Revenue
N/A
$21,500,000.00
Revenue This Year
N/A
$4.51
Revenue Next Year
N/A
$30.29
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.77
$2.16
52 Week High
$4.95
$3.49

Technical Indicators

Market Signals
Indicator
SNTI
DAIO
Relative Strength Index (RSI) 60.11 60.58
Support Level $1.02 $2.64
Resistance Level $1.19 $2.76
Average True Range (ATR) 0.07 0.17
MACD 0.02 0.04
Stochastic Oscillator 69.86 92.98

Price Performance

Historical Comparison
SNTI
DAIO

About SNTI Senti Biosciences Inc.

Senti Biosciences Inc is a clinical-stage biotechnology company developing next-generation cell and gene therapies engineered with its gene circuit platform technologies for patients living with incurable diseases. The product candidates utilize allogeneic chimeric antigen receptor natural killer (CAR-NK) cells outfitted with its gene circuit technologies in various oncology indications. The company product candidates include SENTI-202, a Logic Gated off-the-shelf CAR-NK cell therapy designed to target and eliminate cancer cells while sparing the healthy bone marrow; and SENTI-301A for the treatment of hepatocellular carcinoma.

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

Share on Social Networks: